Trial NCT00276744

View at ClinicalTrials.gov 
Org. Study IDs: J0507
Secondary IDs: 05-04-14-02 CDR0000455000 P30CA006973

Last trial update was posted on 2018-10-24

MeSH Interventions

Capecitabine Cetuximab Docetaxel Erlotinib Hydrochloride Gemcitabine Irinotecan Mitomycin Mitomycins Sirolimus

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Because there was no longer an active laboratory component to this study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID